![Ken Janoski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ken Janoski
Keine laufenden Positionen mehr
Karriereverlauf von Ken Janoski
Ehemalige bekannte Positionen von Ken Janoski
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BioGenerator (Venture Capital)
![]() BioGenerator (Venture Capital) Investment ManagersFinance BioGenerator (Venture Capital) (BioGenerator) is a venture capital subsidiary of BioGenerator founded in 2003. The firm is headquartered in St. Louis, Missouri. | Chief Investment Officer | - | 31.12.2009 |
Private Equity Investor | - | 31.12.2009 | |
Präsident | - | 31.12.2009 | |
Neurolutions, Inc.
![]() Neurolutions, Inc. Medical SpecialtiesHealth Technology Neurolutions, Inc. develops revolutionary platform of devices, based on Brain Computer Interface (BCI) technology, which promise to restore function to patients who are disabled as a result of neurological injury. The company was founded by Eric Leuthhardt, Daniel J. Moran, and Gerwin Schalk on October 1, 2008 and is headquartered in St. Louis, MO. | Direktor/Vorstandsmitglied | 07.08.2009 | - |
Ausbildung von Ken Janoski
University of Missouri | Undergraduate Degree |
University of Washington | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Chief Investment Officer | 1 |
Private Equity Investor | 1 |
President | 1 |
Sektoral
Consumer Services | 3 |
Finance | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
BioGenerator (Venture Capital)
![]() BioGenerator (Venture Capital) Investment ManagersFinance BioGenerator (Venture Capital) (BioGenerator) is a venture capital subsidiary of BioGenerator founded in 2003. The firm is headquartered in St. Louis, Missouri. | Finance |
Neurolutions, Inc.
![]() Neurolutions, Inc. Medical SpecialtiesHealth Technology Neurolutions, Inc. develops revolutionary platform of devices, based on Brain Computer Interface (BCI) technology, which promise to restore function to patients who are disabled as a result of neurological injury. The company was founded by Eric Leuthhardt, Daniel J. Moran, and Gerwin Schalk on October 1, 2008 and is headquartered in St. Louis, MO. | Health Technology |
- Börse
- Insiders
- Ken Janoski
- Erfahrung